Citizens Financial Group Inc. RI Has $640,000 Stock Holdings in The Allstate Corporation $ALL

Citizens Financial Group Inc. RI boosted its holdings in shares of The Allstate Corporation (NYSE:ALL) by 16.4% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,162 shares of the insurance provider’s stock after purchasing an additional 446 shares during the period. Citizens Financial Group Inc. RI’s holdings in Allstate were worth $640,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Arlington Trust Co LLC lifted its stake in Allstate by 261.8% in the 2nd quarter. Arlington Trust Co LLC now owns 123 shares of the insurance provider’s stock valued at $25,000 after purchasing an additional 89 shares during the last quarter. Clearstead Trust LLC increased its holdings in shares of Allstate by 3,800.0% during the second quarter. Clearstead Trust LLC now owns 156 shares of the insurance provider’s stock worth $31,000 after buying an additional 152 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in shares of Allstate by 315.0% in the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 166 shares of the insurance provider’s stock valued at $33,000 after acquiring an additional 126 shares during the last quarter. Hilltop National Bank acquired a new stake in shares of Allstate during the 2nd quarter valued at $34,000. Finally, Chilton Capital Management LLC bought a new stake in Allstate during the 2nd quarter worth $38,000. Institutional investors own 76.47% of the company’s stock.

Allstate Stock Performance

ALL opened at $210.15 on Wednesday. The Allstate Corporation has a 1-year low of $176.00 and a 1-year high of $215.70. The company has a market cap of $54.99 billion, a price-to-earnings ratio of 9.88, a PEG ratio of 0.69 and a beta of 0.35. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.37. The company’s fifty day moving average price is $202.72 and its two-hundred day moving average price is $201.85.

Allstate (NYSE:ALL) last released its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $11.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.48 by $5.69. The business had revenue of $17.26 billion during the quarter, compared to the consensus estimate of $16.59 billion. Allstate had a return on equity of 28.74% and a net margin of 8.79%.The company’s quarterly revenue was up 3.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.91 EPS. On average, analysts expect that The Allstate Corporation will post 18.74 EPS for the current fiscal year.

Insider Buying and Selling

In other Allstate news, insider Suren Gupta sold 400 shares of the stock in a transaction dated Monday, November 17th. The shares were sold at an average price of $215.22, for a total value of $86,088.00. Following the completion of the sale, the insider owned 100,646 shares in the company, valued at approximately $21,661,032.12. This trade represents a 0.40% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.70% of the company’s stock.

Analysts Set New Price Targets

ALL has been the topic of a number of recent research reports. Wolfe Research upgraded shares of Allstate to a “strong-buy” rating in a report on Tuesday, September 16th. Roth Capital set a $230.00 price target on Allstate and gave the company a “buy” rating in a research report on Friday, September 26th. BMO Capital Markets increased their price target on Allstate from $235.00 to $244.00 and gave the company an “outperform” rating in a research note on Friday, November 7th. Raymond James Financial reaffirmed a “strong-buy” rating and issued a $260.00 price objective (up from $250.00) on shares of Allstate in a research note on Monday, August 4th. Finally, JPMorgan Chase & Co. upped their target price on Allstate from $254.00 to $260.00 and gave the company an “overweight” rating in a report on Thursday, November 6th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $237.64.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.